Health
1 read
Uncertainty Surrounds Final Decision on Moderna's mRNA Flu Vaccine for Seniors

Want the full story?
Read the complete article at KTSM
AI Summary
An FDA advisory panel has recommended the use of Moderna's mRNA flu vaccine specifically for older adults. However, the decision-making process is complicated by the absence of a permanent vaccine chief and commissioner at the FDA, leaving uncertainty about who will ultimately approve the vaccine. This recommendation is significant as it could enhance flu protection for seniors, a demographic particularly vulnerable to severe illness. The timeline for a final decision remains unclear, impacting both public health strategies and vaccine availability for the upcoming flu season.
health fda flu vaccine moderna
People & Organizations
FDAModerna